Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 254, 70-77
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Niedersächsisches Ministerium für Wissenschaft und Kultur
- Medtronic
- Deutsche Parkinson Vereinigung
- Deutsche Forschungsgemeinschaft
This publication has 56 references indexed in Scilit:
- Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision makingBrain, 2012
- Subthalamic nucleus stimulation reverses mediofrontal influence over decision thresholdNature Neuroscience, 2011
- Executive functions, categorization of probabilities, and learning from feedback: What does really matter for decision making under explicit risk conditions?Journal of Clinical and Experimental Neuropsychology, 2011
- Dopaminergic Drugs Modulate Learning Rates and Perseveration in Parkinson's Patients in a Dynamic Foraging TaskJournal of Neuroscience, 2009
- Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological studyNeuropsychologia, 2009
- Stimulation of the subthalamic nucleus and impulsivity: Release your horsesAnnals of Neurology, 2009
- The role of strategies in deciding advantageously in ambiguous and risky situationsCognitive Processing, 2008
- Understanding decision-making deficits in neurological conditions: insights from models of natural action selectionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007
- Extrastriatal dopamine D 2 receptors in Parkinson's disease: a longitudinal studyJournal of Neural Transmission, 2003
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988